BCOR mutations define a therapeutic vulnerability to DHODH Inhibition in acute myeloid leukemia.
Saved in:
| Title: | BCOR mutations define a therapeutic vulnerability to DHODH Inhibition in acute myeloid leukemia. |
|---|---|
| Authors: | Robert F; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK. fr392@cam.ac.uk.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK. fr392@cam.ac.uk., Badja C; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK., Boushaki S; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK., Degasperi A; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK., Memari Y; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK., Momen S; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK., Roumeliotis TI; Functional Proteomics Group, Institute of Cancer Research, Chester Betty Labs, London, SW3 6JB, UK., Kozik Z; Functional Proteomics Group, Institute of Cancer Research, Chester Betty Labs, London, SW3 6JB, UK., Gozdecka M; Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, CB2 0AW, UK., Choudhary J; Functional Proteomics Group, Institute of Cancer Research, Chester Betty Labs, London, SW3 6JB, UK., Vassiliou G; Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, CB2 0AW, UK., Koh GC; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK., Nik-Zainal S; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK. |
| Source: | Annals of hematology [Ann Hematol] 2026 Jan 19; Vol. 105 (1), pp. 32. Date of Electronic Publication: 2026 Jan 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9107334 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0584 (Electronic) Linking ISSN: 09395555 NLM ISO Abbreviation: Ann Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41549155 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: BCOR mutations define a therapeutic vulnerability to DHODH Inhibition in acute myeloid leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Robert+F%22">Robert F</searchLink>; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK. fr392@cam.ac.uk.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK. fr392@cam.ac.uk.<br /><searchLink fieldCode="AU" term="%22Badja+C%22">Badja C</searchLink>; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK.<br /><searchLink fieldCode="AU" term="%22Boushaki+S%22">Boushaki S</searchLink>; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK.<br /><searchLink fieldCode="AU" term="%22Degasperi+A%22">Degasperi A</searchLink>; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK.<br /><searchLink fieldCode="AU" term="%22Memari+Y%22">Memari Y</searchLink>; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK.<br /><searchLink fieldCode="AU" term="%22Momen+S%22">Momen S</searchLink>; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK.<br /><searchLink fieldCode="AU" term="%22Roumeliotis+TI%22">Roumeliotis TI</searchLink>; Functional Proteomics Group, Institute of Cancer Research, Chester Betty Labs, London, SW3 6JB, UK.<br /><searchLink fieldCode="AU" term="%22Kozik+Z%22">Kozik Z</searchLink>; Functional Proteomics Group, Institute of Cancer Research, Chester Betty Labs, London, SW3 6JB, UK.<br /><searchLink fieldCode="AU" term="%22Gozdecka+M%22">Gozdecka M</searchLink>; Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, CB2 0AW, UK.<br /><searchLink fieldCode="AU" term="%22Choudhary+J%22">Choudhary J</searchLink>; Functional Proteomics Group, Institute of Cancer Research, Chester Betty Labs, London, SW3 6JB, UK.<br /><searchLink fieldCode="AU" term="%22Vassiliou+G%22">Vassiliou G</searchLink>; Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Puddicombe Way, Cambridge, CB2 0AW, UK.<br /><searchLink fieldCode="AU" term="%22Koh+GC%22">Koh GC</searchLink>; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK.<br /><searchLink fieldCode="AU" term="%22Nik-Zainal+S%22">Nik-Zainal S</searchLink>; Department of Medical Genetics, Level 6 Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Box 238, Cambridge , CB2 0QQ, UK.; Early Cancer Institute, Department of Oncology, Cambridge Biomedical Research Campus, Hutchison Research Centre, Box 197, Cambridge, CB2 0XZ, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229107334%22">Annals of hematology</searchLink> [Ann Hematol] 2026 Jan 19; Vol. 105 (1), pp. 32. <i>Date of Electronic Publication: </i>2026 Jan 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>9107334 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0584 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209395555%22">09395555 </searchLink><i>NLM ISO Abbreviation: </i>Ann Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41549155 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00277-026-06773-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 32 Titles: – TitleFull: BCOR mutations define a therapeutic vulnerability to DHODH Inhibition in acute myeloid leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Robert F – PersonEntity: Name: NameFull: Badja C – PersonEntity: Name: NameFull: Boushaki S – PersonEntity: Name: NameFull: Degasperi A – PersonEntity: Name: NameFull: Memari Y – PersonEntity: Name: NameFull: Momen S – PersonEntity: Name: NameFull: Roumeliotis TI – PersonEntity: Name: NameFull: Kozik Z – PersonEntity: Name: NameFull: Gozdecka M – PersonEntity: Name: NameFull: Choudhary J – PersonEntity: Name: NameFull: Vassiliou G – PersonEntity: Name: NameFull: Koh GC – PersonEntity: Name: NameFull: Nik-Zainal S IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 01 Text: 2026 Jan 19 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1432-0584 Numbering: – Type: volume Value: 105 – Type: issue Value: 1 Titles: – TitleFull: Annals of hematology Type: main |
| ResultId | 1 |